Neoplasms, Endometrial Recruiting Phase 3 Trials for Doxorubicin (DB00997)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03517449Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])Treatment